RBP2 and lung carcinoma: Our observation in OT resistant RMS tumors is largely in line with a previously reported transient and reversible subpopulation of drug-tolerant lung cancer cells that are regulated epigenetically by histone demethylation via the RBP2/KDM5A/Jarid1A axis41.